Month: December 2023
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. – THRX
Contacts Kahn Swick & Foti, LLC Lewis S. Kahn, Managing Partner 855-768-1857 lewis.kahn@ksfcounsel.com Former Attorney General of Louisiana Charles C....
RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. – RYZB
Contacts Kahn Swick & Foti, LLC Lewis S. Kahn lewis.kahn@ksfcounsel.com 855-768-1857 Former Attorney General of Louisiana Charles C. Foti, Jr.,...
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. – KRTX
Contacts Kahn Swick & Foti, LLC Lewis S. Kahn, Managing Partner 855-768-1857 lewis.kahn@ksfcounsel.com Former Attorney General of Louisiana Charles C....
DASEKE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Daseke, Inc. – DSKE
Contacts Kahn Swick & Foti, LLC Lewis S. Kahn lewis.kahn@ksfcounsel.com 855-768-1857 Former Attorney General of Louisiana Charles C. Foti, Jr.,...